These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 27061102)

  • 1. Relationship between psoriasis severity, clinical symptoms, quality of life and work productivity among patients in the USA.
    Korman NJ; Zhao Y; Pike J; Roberts J
    Clin Exp Dermatol; 2016 Jul; 41(5):514-21. PubMed ID: 27061102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased severity of itching, pain, and scaling in psoriasis patients is associated with increased disease severity, reduced quality of life, and reduced work productivity.
    Korman NJ; Zhao Y; Pike J; Roberts J; Sullivan E
    Dermatol Online J; 2015 Oct; 21(10):. PubMed ID: 26632793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Satisfaction with current psoriasis treatment: misalignment between physician and patient perceptions.
    Korman NJ; Zhao Y; Pike J; Roberts J; Sullivan E; Kemhus M
    Dermatol Online J; 2016 Jul; 22(7):. PubMed ID: 27617714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of psoriasis flare and remission on quality of life and work productivity: a real-world study in the USA.
    Korman NJ; Zhao Y; Roberts J; Pike J; Sullivan E; Tsang Y; Karagiannis T
    Dermatol Online J; 2016 Jul; 22(7):. PubMed ID: 27617715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pruritus and quality of life in moderate-to-severe plaque psoriasis: post hoc explorative analysis from the PRISTINE study.
    Mrowietz U; Chouela EN; Mallbris L; Stefanidis D; Marino V; Pedersen R; Boggs RL
    J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1114-20. PubMed ID: 25376448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of psoriasis severity on patient-reported clinical symptoms, health-related quality of life and work productivity among US patients: real-world data from the Corrona Psoriasis Registry.
    Strober B; Greenberg JD; Karki C; Mason M; Guo N; Hur P; Zhao Y; Herrera V; Lin F; Lebwohl M
    BMJ Open; 2019 Apr; 9(4):e027535. PubMed ID: 31005939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of secukinumab vs. ustekinumab for treatment of psoriasis on quality of life, work productivity and activity impairment: a structural equation modelling analysis.
    Stull DE; Griffiths CEM; Gilloteau I; Zhao Y; Guana A; Finlay AY; Sherif B; Houghton K; Puig L
    Br J Dermatol; 2018 Jun; 178(6):1297-1307. PubMed ID: 29355896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis.
    Luger TA; Barker J; Lambert J; Yang S; Robertson D; Foehl J; Molta CT; Boggs R
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):896-904. PubMed ID: 19453794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis.
    Davison NJ; Thompson AJ; Turner AJ; Longworth L; McElhone K; Griffiths CEM; Payne K;
    Value Health; 2018 Aug; 21(8):1010-1018. PubMed ID: 30098665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis.
    Kimball AB; Yu AP; Signorovitch J; Xie J; Tsaneva M; Gupta SR; Bao Y; Mulani PM
    J Am Acad Dermatol; 2012 Feb; 66(2):e67-76. PubMed ID: 21616560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient satisfaction with current psoriasis treatment: a real-world study in the USA.
    Korman NJ; Zhao Y; Pike J; Roberts J; Sullivan E
    Dermatol Online J; 2016 Feb; 22(2):. PubMed ID: 27267186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study.
    Shikiar R; Willian MK; Okun MM; Thompson CS; Revicki DA
    Health Qual Life Outcomes; 2006 Sep; 4():71. PubMed ID: 17005043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cross-sectional study in young adults with psoriasis: potential determining factors in quality of life, life course and work productivity.
    Bronckers IMGJ; van Geel MJ; van de Kerkhof PCM; de Jong EMGJ; Seyger MMB
    J Dermatolog Treat; 2019 May; 30(3):208-215. PubMed ID: 30102075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of adalimumab treatment on patient-reported outcomes: results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis.
    Revicki DA; Willian MK; Menter A; Gordon KB; Kimball AB; Leonardi CL; Langley RG; Kimel M; Okun M
    J Dermatolog Treat; 2007; 18(6):341-50. PubMed ID: 18058494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: a cross-sectional, observational study.
    Gibson PR; Vaizey C; Black CM; Nicholls R; Weston AR; Bampton P; Sparrow M; Lawrance IC; Selby WS; Andrews JM; Walsh AJ; Hetzel DJ; Macrae FA; Moore GT; Weltman MD; Leong RW; Fan T
    J Crohns Colitis; 2014 Jul; 8(7):598-606. PubMed ID: 24345767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multidimensional assessment of the burden of psoriasis: results from a multinational dermatologist and patient survey.
    Griffiths CEM; Jo SJ; Naldi L; Romiti R; Guevara-Sangines E; Howe T; Pietri G; Gilloteau I; Richardson C; Tian H; Augustin M
    Br J Dermatol; 2018 Jul; 179(1):173-181. PubMed ID: 29328510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of psoriatic patients at risk of high quality of life impairment.
    Sojević Timotijević Z; Janković S; Trajković G; Majcan P; Perišić S; Dostanić N; Janićijević Hudomal S; Janković J
    J Dermatol; 2013 Oct; 40(10):797-804. PubMed ID: 23961725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Willingness-to-pay and quality of life in patients with vitiligo.
    Radtke MA; Schäfer I; Gajur A; Langenbruch A; Augustin M
    Br J Dermatol; 2009 Jul; 161(1):134-9. PubMed ID: 19298268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Skindex-29, Dermatology Life Quality Index, Psoriasis Disability Index and Medical Outcome Study Short Form 36 in patients with mild to severe psoriasis.
    Fernandez-Peñas P; Jones-Caballero M; Espallardo O; García-Díez A
    Br J Dermatol; 2012 Apr; 166(4):884-7. PubMed ID: 22229951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the Dermatology Life Quality Index work/study domain to estimate overall work productivity loss among patients with psoriasis: an analysis based on real-world data.
    Li N; Teeple A; Muser E; Lucas J; Hetherington J; Fitzgerald T
    Clin Exp Dermatol; 2020 Jul; 45(5):572-575. PubMed ID: 31736108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.